http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005203192-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-03 |
| filingDate | 2005-03-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ea5ac1d5a1ddb3a109bfdf35c18262 |
| publicationDate | 2005-09-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005203192-A1 |
| titleOfInvention | Process and composition for treating viral infections |
| abstract | A method and composition for treating herpes group viral infection in a host that reduces the duration and severity of lesions associated therewith. A therapeutically effective amount of a halogenated hydrocarbon compound is applied topically to the affected tissue in a dosage or frequency sufficient to speed healing of the affected tissue. Halogenated hydrocarbons may include organochlorides (such as methyl chlorides and ethyl chlorides), alkyl chlorides, alkyl bromides, and alkyl fluorides (such as methyl fluoride). Other compounds known to be effective in decreasing the recurrence of the herpes group virus in a dosage to speed healing of infected tissue may also be combined and applied. Such other compounds may include acyclovir, famcyclovir, viral thymidine kinase inhibitor, and other partially effective herpes simplex viral recurrence inhibitors known in the art. |
| priorityDate | 2004-03-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 343 of 343.